???global.info.a_carregar???
Identification

Personal identification

Full name
MÁRIO MIGUEL COELHO DA SILVA ROSA

Citation names

  • ROSA, MÁRIO MIGUEL
  • MM ROSA
  • MÁRIO ROSA
  • MARIO MIGUEL ROSA
  • MÁRIO MIGUEL ROSA
  • MÁRIO-MIGUEL ROSA
  • Rosa MM

Author identifiers

Ciência ID
AD12-9209-3302
ORCID iD
0000-0003-3158-2106
Scopus Author Id
57210527367

Email addresses

  • mrosa@medicina.ulisboa.pt (Professional)

Telephones

Telephone
  • 215962953 (Professional)

Addresses

  • Laboratorio de Farmacologia Clinica e Terapeutica Faculdade de Medicina da Universidade de Lisboa Av. Prof. Egas Moniz, 1649-028 , LISBOA, LISBOA, Portugal (Professional)
  • Centro de Estudos Egas Moniz, Faculdade de Medicina da Universidade de Lisboa, Av Prof Egas Moniz, 1649-028, Lisboa, Lisboa, Portugal (Professional)

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Proficiency (C2) Proficiency (C2) Proficiency (C2)
French Intermediate (B1) Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2)
Italian Intermediate (B1) Upper intermediate (B2) Elementary (A2) Upper intermediate (B2)
Portuguese Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Education
Degree Classification
2016/07/08
Concluded
 Medicina (Doutoramento)
Major in Especialidade: Farmacologia
Universidade de Lisboa Faculdade de Medicina, Portugal
"PRESCRIPTION PATTERN OF ANTIPARKINSONIAN AGENTS: CHARACTERIZATION OF USE BY CLINICIANS PADRÃO DE PRESCRIÇÃO DE AGENTES ANTIPARKINSÓNICOS: CARACTERIZAÇÃO DO USO PELOS CLÍNICOS" (THESIS/DISSERTATION)
 Louvor e Distinção
2008
Concluded
 Farmacologia Clínica (Título de especialista)
Ordem dos Médicos, Portugal
1998/02
Concluded
 Neurologia (Título de especialista)
Hospital de Santa Maria, Portugal

Ordem dos Médicos, Portugal
1993 - 1998
Concluded
 Internato Complementar de Neurologia (Especialização pós-licenciatura)
Hospital de Santa Maria, Portugal
1984/10/08 - 1990/07
Concluded
 Medicina (Licenciatura)
Universidade de Lisboa Faculdade de Medicina, Portugal
 16,24 val.
Affiliation

Teaching in Higher Education

Category
Host institution 		Employer
2016/10 - Current Invited Assistant Professor (University Teacher) Universidade de Lisboa Faculdade de Medicina, Portugal
Instituto de Medicina Molecular João Lobo Antunes, Portugal
2016/10 - Current Invited Assistant Professor (University Teacher) Universidade de Lisboa Faculdade de Medicina, Portugal
2015 - Current Visiting Professor (University Teacher) Universidade de Lisboa Centro de Investigação em Direito Penal e Penal Ciências, Portugal
2007 - 2016/09/30 Lecturer (University Teacher) Instituto de Medicina Molecular João Lobo Antunes, Portugal
1998/06/23 - 2016/09/30 Lecturer (University Teacher) Universidade de Lisboa Faculdade de Medicina, Portugal

Other Careers

Category
Host institution 		Employer
2016/06/25 - Current Assistente graduado (Médica) Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2012/06/25 - Current Assistente graduado (Médica) Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2001/06/01 - 2012/06/24 Assistente (Médica) Hospital de Santa Maria, Portugal

Positions / Appointments

Category
Host institution 		Employer
2011/12/01 - 2019/04/30 Organic Unit Director Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal

Others

Category
Host institution 		Employer
1998/03/01 - 2016/08 Clinical Pharmacology Consultant at Economic Evaluation and Market Monitoring Department Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP, Portugal
2000/06/01 - 2011/11/30 Lisbon Pharmacovigilance Unit Medical Coordinator Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal
2000/01/01 - 2011/05/31 Principal Investigator: Clinical Trials on Movement disorders, Dementia and Pain Hospital de Santa Maria, Portugal
1990/09/01 - 2011/05/31 Investigator: Clinical Trials on Movement disorders, Dementia, Pain, Stroke, Multiple sclerosis and Neurotrauma Hospital de Santa Maria, Portugal
Projects

Contract

Designation Funders
2014/03/01 - 2017/10/31 COmprehensive Unbiased Risk factor Assessment for Genetics and Environment in Parkinson‘s Disease
JPND-RF/0001/2012
Instituto de Medicina Molecular João Lobo Antunes, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2014/04/30 - 2017/10/28 Care for Late Stage Parkinsonism
JPND-HC/0002/2012
Instituto de Medicina Molecular João Lobo Antunes, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2009/01/01 - 2012/12/31 Slow and Rapid Progression Parkinson´s Disease: Molecular Determinants and Biomarkers
PIC/IC/82760/2007
Instituto de Medicina Molecular João Lobo Antunes, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2005/10/15 - 2007/12/31 Evaluation of the health impact of chronic neurological disorders. A Contribution to the definition of relevant patient-based outcomes and to the methodology of health services assessment.
POCI/SAU-ESP/59293/2004
Instituto de Medicina Molecular João Lobo Antunes, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Book chapter
  1. Rosa, Mário Miguel; Dias, Teresa. "Commonly used endocrine drugs". In Neurologic Aspects of Systemic Disease Part II, 809-824. Elsevier, 2014.
    10.1016/b978-0-7020-4087-0.00054-1
Conference paper
  1. Fabbri, Margherita; Guimarães, Isabel; Coelho, Miguel; Cardoso, R.; Guedes, Leonor Correia; Rosa, Mario M.; Godinho, Catarina; Antonini, Angelo; Ferreira, Joaquim J.. "Speech and voice response to levodopa in late-stage Parkinson’s Disease patients : report from an acute levodopa challenge". 2017.
  2. Sousa, Teresa Almeida e; Ferret-Sena, Véronique; Coelho, Miguel; Correia-Guedes, Leonor; Fabbri, Margherita; Rosa, Mário Miguel; Godinho, Catarina. "Main reasons for rejection of deep brain stimulation surgery in candidates with Parkinson Disease". 2017.
    10.1080/07853890.2018.1427445
  3. Fabbri, Margherita; Reimão, Sofia; Carvalho, Miguel; Nunes, Rita G.; Abreu, Daisy; Guedes, Leonor Correia; Bouça, Raquel; et al. "Substantia nigra area evaluated by neuromelanin-sensitive MRI as an imaging biomarker of disease progression in Parkinson's disease". 2017.
  4. Freitas, Vanda; Coelho, Miguel; Albuquerque, Luísa; Godinho, Catarina; Rosa, Mário Miguel; Martins, Isabel Pavão. "Avaliação do Estado Mental para Estimulação Cerebral Profunda: “ON” vs. “OFF”". 2015.
Journal article
  1. Cerreta, F.; Iskra, E.B.; Cupelli, A.; Sepodes, B.; Rönnemaa, E.; Rosa, M.M.; Mayrhofer, S.; et al. "Medicines for an aging population: The EMA perspective and policies". Journal of the American Geriatrics Society (2024): http://www.scopus.com/inward/record.url?eid=2-s2.0-85193607660&partnerID=MN8TOARS.
    10.1111/jgs.18953
  2. Fuggle, N.R.; Beaudart, C.; Bruyère, O.; Abrahamsen, B.; Al-Daghri, N.; Burlet, N.; Chandran, M.; et al. "Evidence-Based Guideline for the management of osteoporosis in men". Nature Reviews Rheumatology 20 4 (2024): 241-251. http://www.scopus.com/inward/record.url?eid=2-s2.0-85187870842&partnerID=MN8TOARS.
    10.1038/s41584-024-01094-9
  3. Rosário, M.; Carvalho, V.; Moldovan, O.; Crawford, J.; Chendo, I.; Reimão, S.; Rosa, M.M.; Correia Guedes, L.. "HSD10 disease in a female patient with juvenile onset parkinsonism". Movement Disorders Clinical Practice 11 4 (2024): 431-433. http://www.scopus.com/inward/record.url?eid=2-s2.0-85186447998&partnerID=MN8TOARS.
    10.1002/mdc3.13917
  4. Barbosa, R.; Mendonça, M.; Bastos, P.; Pita Lobo, P.; Valadas, A.; Correia Guedes, L.; Ferreira, J.J.; et al. "3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS-Unified Parkinson's Disease Rating Scale in Patients with Motor Complications". Movement Disorders Clinical Practice (2024): http://www.scopus.com/inward/record.url?eid=2-s2.0-85190524283&partnerID=MN8TOARS.
    10.1002/mdc3.14016
  5. Barbosa R; Guedes LC; Cattoni MB; Lobo PP; Caldas AC; Fabbri M; Bastos P; et al. "Long-term follow-up of subthalamic nucleus deep brain stimulation in patients with Parkinson's disease: An analysis of survival and disability milestones.". Parkinsonism & related disorders (2023): http://europepmc.org/abstract/med/37976978.
    10.1016/j.parkreldis.2023.105921
  6. Denkinger M; Knol W; Cherubini A; Simonds A; Lionis C; Lacombe D; Petelos E; et al. "Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults.". The lancet. Healthy longevity (2023): http://europepmc.org/abstract/med/37977177.
    10.1016/s2666-7568(23)00208-8
  7. Mario Miguel Rosa; Thierry Chevalley; Maria Luisa Brandi; Kevin D. Cashman; Etienne Cavalier; Nicholas C. Harvey; Stefania Maggi; et al. "Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group". Aging Clinical and Experimental Research 34 11 (2022): 2603-2623. http://dx.doi.org/10.1007/s40520-022-02279-6.
    10.1007/s40520-022-02279-6
  8. ROSA, MÁRIO MIGUEL; Nicola Veronese; Cyrus Cooper; Bruyère O; Al-Daghri NM; Branco J; Cavalier E; et al. "Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations.". Drugs (2022): https://europepmc.org/articles/PMC9512723.
    10.1007/s40265-022-01773-5
  9. Mario Miguel Rosa; Verónica Caniça; Raquel Bouça-Machado; Mário Miguel Rosa; Joaquim J. Ferreira; Daniela Guerreiro; Raquel Nunes; et al. "Adverse Events of Physiotherapy Interventions in Parkinsonian Patients". Movement Disorders Clinical Practice 9 6 (2022): 744-750. http://dx.doi.org/10.1002/mdc3.13466.
    10.1002/mdc3.13466
  10. Mario Miguel Rosa; Nicholas Fuggle; Nathalie Bere; Olivier Bruyère; Mario Manuel Rosa; María Concepción Prieto Yerro; Elaine Dennison; et al. "Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach". Aging Clinical and Experimental Research 34 9 (2022): 1985-1995. http://dx.doi.org/10.1007/s40520-022-02176-y.
    10.1007/s40520-022-02176-y
  11. Andrea Trombetti; Nasser Al-Daghri; Maria Luisa Brandi; Jorge B. Cannata-Andía; Etienne Cavalier; Manju Chandran; Catherine Chaussain; et al. "Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia". Nature Reviews Endocrinology 18 6 (2022): 366-384. http://dx.doi.org/10.1038/s41574-022-00662-x.
    10.1038/s41574-022-00662-x
  12. Mario Miguel Rosa; Elizabeth Curtis; JEAN-YVES REGINSTER; Nasser Al-Daghri; Emmanuel BIVER; maria luisa brandi; Etienne Cavalier; et al. "Management of patients at very high risk of osteoporotic fractures through sequential treatments.". Aging clinical and experimental research (2022): https://europepmc.org/articles/PMC9076733.
    10.1007/s40520-022-02100-4
  13. Mainoli, B.; Avo-Baiao, R.; Craciun, A.; Carvalhana, S.; Moura, M.; Freitas, C.; Rosa, M.; Cortez-Pinto, H.. "Portuguese single-centre series of suspected drug-inducedliver injury (DILI) cases included in the Pro-Euro-DILIRegistry". European Journal of Clinical Pharmacology (2022): https://publons.com/wos-op/publon/57845735/.
  14. ROSA, MÁRIO MIGUEL. "miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson's Disease.". Frontiers in cell and developmental biology (2021): https://europepmc.org/articles/PMC8239393.
    10.3389/fcell.2021.661461
  15. ROSA, MÁRIO MIGUEL. "The Risk of Mortality Associated With Opioid Use in Patients With Acute Heart Failure: Systematic Review and Meta-analysis.". Journal of cardiovascular pharmacology (2021): https://doi.org/10.1097/FJC.0000000000000954.
    10.1097/fjc.0000000000000954
  16. ROSA, MÁRIO MIGUEL. "The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis". Clinical Research in Cardiology 110 2 (2021): 183-193. http://dx.doi.org/10.1007/s00392-020-01697-8.
    10.1007/s00392-020-01697-8
  17. ROSA, MÁRIO MIGUEL. "Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults". Aging Clinical and Experimental Research 33 1 (2021): 3-17. http://dx.doi.org/10.1007/s40520-020-01663-4.
    10.1007/s40520-020-01663-4
  18. ROSA, MÁRIO MIGUEL. "A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy". BMC Neurology 20 1 (2020): http://dx.doi.org/10.1186/s12883-020-02007-5.
    10.1186/s12883-020-02007-5
  19. Bouça-Machado, Raquel; Gonçalves, Nilza; Lousada, Inês; Patriarca, Maria A.; Costa, Patrícia; Nunes, Raquel; Dias, Susana; et al. "Patients and Health Professional's Perspective of Functional Mobility in Parkinson's Disease". Frontiers in Neurology 11 (2020): http://dx.doi.org/10.3389/fneur.2020.575811.
    10.3389/fneur.2020.575811
  20. Patrícia Lindeza; Mário Rodrigues; João Costa; Manuela Guerreiro; Mario Miguel Rosa. "Impact of dementia on informal care: a systematic review of family caregivers’ perceptions". BMJ Supportive & Palliative Care (2020): bmjspcare--2020--002-bmjspcare--2020--002. https://doi.org/10.1136/bmjspcare-2020-002242.
    10.1136/bmjspcare-2020-002242
  21. ROSA, MÁRIO MIGUEL. "Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.". Biomolecules (2020): https://europepmc.org/articles/PMC7356527.
    10.3390/biom10060945
  22. Mainoli, Beatrice; Carvalho Dias, Mariana; Canhão, Patricia; Rosa, Mário Miguel. "Suspected adverse reaction to compounded preparations prescribed for weight loss: two cases of cerebral venous thrombosis". BMJ Case Reports 13 3 (2020): e233746. http://dx.doi.org/10.1136/bcr-2019-233746.
    Published • 10.1136/bcr-2019-233746
  23. Mario Miguel Rosa; Cristiana Freixo; Vítor Ferreira; Joana Martins; Rui Almeida; Daniel Caldeira; Mário Rosa; João Costa; Joaquim Ferreira. "Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review". Journal of Vascular Surgery 71 1 (2020): 318-327. http://dx.doi.org/10.1016/j.jvs.2019.06.217.
    10.1016/j.jvs.2019.06.217
  24. Silva, D.; Fabbri, M.; Guedes, L.; Caldas, A. C.; Pita Lobo, P.; Cattoni, B.; Carvalho, H.; et al. "The role of the London Handicap Scale in the evaluation of Parkinson's Disease patients before and after DBS-STN". European Journal of Neurology (2020): https://publons.com/wos-op/publon/63627736/.
  25. ROSA, MÁRIO MIGUEL. "New harmonized considerations on the evaluation instruments for baseline characterization of frailty in the European Union.". British journal of clinical pharmacology (2019): https://europepmc.org/articles/PMC7495266.
    10.1111/bcp.14044
  26. Haberkamp, Marion; Moseley, Jane; Athanasiou, Dimitrios; de Andres-Trelles, Fernando; Elferink, André; Rosa, Mário Miguel; Magrelli, Armando. "European regulators’ views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials". Neuromuscular Disorders 29 7 (2019): 514-516. http://dx.doi.org/10.1016/j.nmd.2019.06.003.
    10.1016/j.nmd.2019.06.003
  27. Fabbri, Margherita; Coelho, Miguel; Abreu, Daisy; Guedes, Leonor Correia; Rosa, Mario M.; Godinho, Catarina; Cardoso, Rita; et al. "Dysphagia predicts poor outcome in late-stage Parkinson's disease". (2019): http://hdl.handle.net/10400.26/29986.
    10.1016/j.parkreldis.2019.02.043
  28. Fabbri, Margherita; Rosa, Mario M.; Ferreira, Joaquim J.. "Adjunctive Therapies in Parkinson’s Disease: How to Choose the Best Treatment Strategy Approach". Drugs & Aging 35 12 (2018): 1041-1054. http://dx.doi.org/10.1007/s40266-018-0599-2.
    10.1007/s40266-018-0599-2
  29. ROSA, MÁRIO MIGUEL. "Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.". Expert opinion on drug safety (2018): https://doi.org/10.1080/14740338.2018.1439474.
    10.1080/14740338.2018.1439474
  30. ROSA, MÁRIO MIGUEL. "Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.". PloS one (2017): https://europepmc.org/articles/PMC5746279.
    10.1371/journal.pone.0190552
  31. ROSA, MÁRIO MIGUEL. "Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease.". Frontiers in neurology (2017): https://europepmc.org/articles/PMC5572389.
    10.3389/fneur.2017.00432
  32. ROSA, MÁRIO MIGUEL. "Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.". Parkinsonism & related disorders (2017): https://doi.org/10.1016/j.parkreldis.2017.05.003.
    10.1016/j.parkreldis.2017.05.003
  33. Aartsma-Rus, Annemieke; Balabanov, Pavel; Binetti, Luca; Haas, Manuel; Haberkamp, Marion; Mitchell, Joanna; Rosa, Mário Miguel; et al. "Stakeholder collaboration for spinal muscular atrophy therapy development". The Lancet Neurology 16 4 (2017): 264. http://dx.doi.org/10.1016/s1474-4422(17)30041-8.
    10.1016/s1474-4422(17)30041-8
  34. ROSA, MÁRIO MIGUEL. "Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.". Parkinsonism & related disorders (2017): https://doi.org/10.1016/j.parkreldis.2017.02.007.
    10.1016/j.parkreldis.2017.02.007
  35. Fabbri, Margherita; Reimão, Sofia; Carvalho, Miguel; Nunes, Rita G.; Abreu, Daisy; Guedes, Leonor Correia; Bouça, Raquel; et al. "Substantia nigra neuromelanin as an imaging biomarker of disease progression in Parkinson’s Disease". Journal of Parkinson's Disease 7 3 (2017): 491-501. http://hdl.handle.net/10400.26/29906.
    10.3233/JPD-171135
  36. Coelho, Miguel; Abreu, Daisy; Correia-Guedes, Leonor; Lobo, Patrícia Pita; Fabbri, Margherita; Godinho, Catarina; Domingos, Josefa; et al. "Disability in activities of daily living and severity of dyskinesias determine the handicap of Parkinson's disease patients in advanced stage selected to dbs". (2017): http://hdl.handle.net/10400.26/29900.
    10.3233/JPD-160848
  37. Guedes, Leonor Correia; Reimão, Sofia; Paulino, Patrícia; Nunes, Rita G.; Bouça-Machado, Raquel; Abreu, Daisy; Gonçalves, Nilza; et al. "Neuromelanin magnetic resonance imaging of the Substantia Nigra in LRRK2-related Parkinson’s Disease". (2017): http://hdl.handle.net/10400.26/29908.
    10.1002/mds.27083
  38. Miranda, Hugo Vicente; Cássio, Rafaela; Correia-Guedes, Leonor; Gomes, Marcos António; Chegão, Ana; Miranda, Elisa; Soares, Tiago; et al. "Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease". Scientific reports (2017): http://www.scopus.com/inward/record.url?scp=85032025050&partnerID=8YFLogxK.
    https://doi.org/10.1038/s41598-017-14175-5
  39. Fabbri, Margherita; Rosa, Mario M; Ferreira, Joaquim J. "Clinical pharmacology review of opicapone for the treatment of Parkinson's disease". Neurodegenerative Disease Management 6 5 (2016): 349-362. http://dx.doi.org/10.2217/nmt-2016-0022.
    10.2217/nmt-2016-0022
  40. ROSA, MÁRIO MIGUEL. "Clinical manifestations of intermediate allele carriers in Huntington disease.". Neurology (2016): https://doi.org/10.1212/WNL.0000000000002944.
    10.1212/wnl.0000000000002944
  41. ROSA, MÁRIO MIGUEL; Pinho, Raquel; Guedes, Leonor C; Soreq, Lilach; Lobo, Patricia P; Mestre, Tiago; Coelho, Miguel; et al. "Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.". PloS one (2016): https://europepmc.org/articles/PMC4913914.
    10.1371/journal.pone.0157852
  42. Fabbri, Margherita; Coelho, Miguel; Abreu, Daisy; Guedes, Leonor Correia; Rosa, Mario M.; Costa, Nilza; Antonini, Angelo; Ferreira, Joaquim J.. "Do patients with late-stage Parkinson's disease still respond to levodopa?". Parkinsonism & Related Disorders 26 (2016): 10-16. http://dx.doi.org/10.1016/j.parkreldis.2016.02.021.
    10.1016/j.parkreldis.2016.02.021
  43. Ferreira, Joaquim J.; Mestre, Tiago; Guedes, Leonor Correia; Coelho, Miguel; Rosa, Mário M.; Santos, Ana T.; Barra, Márcio; Sampaio, Cristina; Rascol, Olivier. "Espresso Coffee for the Treatment of Somnolence in Parkinson’s Disease: Results of n-of-1 Trials". Frontiers in Neurology 7 (2016): http://dx.doi.org/10.3389/fneur.2016.00027.
    10.3389/fneur.2016.00027
  44. F. Cerreta; D. Bowen; J. Ankri; A. Cherubini; A.J. Cruz Jentoft; A. Guðmundsson; M. Haberkamp; et al. "BASELINE FRAILTY EVALUATION IN DRUG DEVELOPMENT". The Journal of Frailty & Aging 5 3 (2016): 149-140.
    Published • http://dx.doi.org/10.14283/jfa.2016.99
  45. Fabbri, Margherita; ROSA, MÁRIO MIGUEL; Abreu, Daisy; Ferreira, Joaquim J. "Clinical pharmacology review of safinamide for the treatment of Parkinson’s disease". Neurodegenerative Disease Management 5 6 (2015): 481-496. http://dx.doi.org/10.2217/nmt.15.46.
    10.2217/nmt.15.46
  46. Albuquerque, Luisa; Martins, Maurício; Coelho, Miguel; Guedes, Leonor; Ferreira, Joaquim J.; Rosa, Mário; Martins, Isabel Pavão. "Advanced Parkinson disease patients have impairment in prosody processing". Journal of Clinical and Experimental Neuropsychology 38 2 (2015): 208-216. http://dx.doi.org/10.1080/13803395.2015.1100279.
    10.1080/13803395.2015.1100279
  47. Reimão, Sofia; Pita Lobo, Patrícia; Neutel, Dulce; Guedes, Leonor Correia; Coelho, Miguel; ROSA, MÁRIO MIGUEL; Ferreira, Joana; et al. "Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease". Journal of Parkinson's Disease 5 3 (2015): 561-567. http://dx.doi.org/10.3233/jpd-150551.
    10.3233/jpd-150551
  48. Teodoro, Tiago; Nzwalo, Hipólito; Correia Guedes, Leonor; Coelho, Miguel; ROSA, MÁRIO MIGUEL; Ferreira, Joaquim J.. "Suicidal behaviors are very rare in antiparkinsonian drug trials". Parkinsonism & Related Disorders 21 8 (2015): 1008-1009. http://dx.doi.org/10.1016/j.parkreldis.2015.06.011.
    10.1016/j.parkreldis.2015.06.011
  49. ROSA, MÁRIO MIGUEL; Rodrigues,Inês Tello; Ferreira,Joaquim J.; Coelho,Miguel; Rosa,Mario M.; Castro-Caldas,Alexandre. "Action verbal fluency in Parkinson's patients.". Arquivos de neuro-psiquiatria (2015): https://doi.org/10.1590/0004-282X20150056.
    10.1590/0004-282x20150056
  50. ROSA, MÁRIO MIGUEL. "Eye of the Tiger Sign and Very Late Onset in Dentatorubral-Pallidoluysian Atrophy.". Movement disorders clinical practice (2015): https://europepmc.org/articles/PMC6353528.
    10.1002/mdc3.12179
  51. Reimão, Sofia; Pita Lobo, Patrícia; Neutel, Dulce; Guedes, Leonor Correia; Coelho, Miguel; Rosa, Mário M.; Azevedo, Pedro; et al. "Substantia nigraneuromelanin-MR imaging differentiates essential tremor from Parkinson's disease". Movement Disorders 30 7 (2015): 953-959. http://dx.doi.org/10.1002/mds.26182.
    10.1002/mds.26182
  52. Reimão, S.; Pita Lobo, P.; Neutel, D.; Correia Guedes, L.; Coelho, M.; ROSA, MÁRIO MIGUEL; Ferreira, J.; et al. "Substantia nigra neuromelanin magnetic resonance imaging inde novoParkinson's disease patients". European Journal of Neurology 22 3 (2014): 540-546. http://dx.doi.org/10.1111/ene.12613.
    10.1111/ene.12613
  53. Coelho, M.; Marti, M. J.; Sampaio, C.; Ferreira, J. J.; Valldeoriola, F.; Rosa, M. M.; Tolosa, E.. "Dementia and severity of parkinsonism determines the handicap of patients in late-stage Parkinson's disease: the Barcelona-Lisbon cohort". European Journal of Neurology 22 2 (2014): 305-312. http://dx.doi.org/10.1111/ene.12567.
    10.1111/ene.12567
  54. Fabbri, M.; Guedes, L. C.; Coelho, M.; Simão, D.; Abreu, D.; ROSA, MÁRIO MIGUEL; Silveira-Moriyama, L.; Ferreira, J. J.. "Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease". European Journal of Neurology 22 1 (2014): 207-210. http://dx.doi.org/10.1111/ene.12396.
    10.1111/ene.12396
  55. Albuquerque, Luisa; Coelho, Miguel; Martins, Maurício; Guedes, Leonor Correia; ROSA, MÁRIO MIGUEL; Ferreira, Joaquim J.; Cattoni, Maria Begoña; et al. "STN-DBS does not change emotion recognition in advanced Parkinson's disease". Parkinsonism & Related Disorders 20 2 (2014): 166-169. http://dx.doi.org/10.1016/j.parkreldis.2013.10.010.
    10.1016/j.parkreldis.2013.10.010
  56. Zhang, Lei; Quadri, Marialuisa; Guedes, Leonor Correia; Coelho, Miguel; Valadas, Anabela; Mestre, Tiago; Lobo, Patrícia Pita; et al. "Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: Identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants". Parkinsonism & Related Disorders 19 10 (2013): 897-900. http://dx.doi.org/10.1016/j.parkreldis.2013.05.003.
    10.1016/j.parkreldis.2013.05.003
  57. Pita Lobo, Patrícia; Coelho, Miguel; Mestre, Tiago A.; ROSA, MÁRIO MIGUEL; Ferreira, Joaquim J.. "Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism". Movement Disorders 28 9 (2013): 1212-1214. http://dx.doi.org/10.1002/mds.25556.
    10.1002/mds.25556
  58. Teodoro, Tiago; Neutel, Dulce; Lobo, Patrícia; Geraldo, Ana F.; Conceição, Isabel; Rosa, Mário M.; Albuquerque, Luísa; Ferreira, Joaquim J.. "Recovery after copper-deficiency myeloneuropathy in Wilson’s disease". Journal of Neurology 260 7 (2013): 1917-1918. http://dx.doi.org/10.1007/s00415-013-6963-6.
    10.1007/s00415-013-6963-6
  59. Valadas, Anabela; Coelho, Miguel; Mestre, Tiago; Guedes, Leonor Correia; Finisterra, Maria; Noronha, Ana; ROSA, MÁRIO MIGUEL; Sampaio, Cristina; Ferreira, Joaquim J.. "What motivates Parkinson’s disease patients to enter clinical trials?". Parkinsonism & Related Disorders 17 9 (2011): 667-671. http://dx.doi.org/10.1016/j.parkreldis.2011.05.023.
    10.1016/j.parkreldis.2011.05.023
  60. Martins, Madalena; Rosa, Alexandra; Guedes, Leonor C.; Fonseca, Benedita V.; Gotovac, Kristina; Violante, Sara; Mestre, Tiago; et al. "Convergence of miRNA Expression Profiling, a-Synuclein Interacton and GWAS in Parkinson's Disease". PLoS ONE 6 10 (2011): e25443. http://dx.doi.org/10.1371/journal.pone.0025443.
    10.1371/journal.pone.0025443
  61. Lobo, P. P.; Coelho, M.; Geraldes, R.; Santos, C.; Gracio, M.; ROSA, MÁRIO MIGUEL; Antunes, J. L.. "Myeloradiculopathy associated to Schistosoma mansoni". Case Reports 2011 aug11 1 (2011): bcr1220103631-bcr1220103631. http://dx.doi.org/10.1136/bcr.12.2010.3631.
    10.1136/bcr.12.2010.3631
  62. Teodoro, Tiago; Pires, Daniela; ROSA, MÁRIO MIGUEL; Coelho, Miguel; Sampaio, Cristina; Ferreira, Joaquim J.. "Has “levodopa-induced neuropathy” been reported in Parkinson's disease clinical trials?". Movement Disorders 26 10 (2011): 1966-1967. http://dx.doi.org/10.1002/mds.23760.
    10.1002/mds.23760
  63. Reimão, S.; Morgado, C.; Neto, L.; Ferreira, J.; Coelho, M.; Rosa, M.; Campos, J.. "Diffusion Tensor Imaging in Movement Disorders: Review of Major Patterns and Correlation with Normal Brainstem/cerebellar White Matter". The Neuroradiology Journal 24 2 (2011): 177-186. http://dx.doi.org/10.1177/197140091102400203.
    10.1177/197140091102400203
  64. Reese JP; Winter Y; ROSA, MÁRIO MIGUEL; Rodrigues e Silva AM; von Campenhausen S; Balzer-Geldsetzer M; Botzel K; et al. "Health-economic burden of Parkinson's disease in Portugal: a cohort study". Revista de Neurología 52 5 (2011): 264-274.
    Published
  65. Correia Guedes, L.; Ferreira, J.J.; ROSA, MÁRIO MIGUEL; Coelho, M.; Bonifati, V.; Sampaio, C.. "Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review". Parkinsonism & Related Disorders 16 4 (2010): 237-242. http://dx.doi.org/10.1016/j.parkreldis.2009.11.004.
    10.1016/j.parkreldis.2009.11.004
  66. Coelho, Miguel; Marti, Maria J.; Tolosa, Eduardo; Ferreira, Joaquim J.; Valldeoriola, Francesc; ROSA, MÁRIO MIGUEL; Sampaio, Cristina. "Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort". Journal of Neurology 257 9 (2010): 1524-1532. http://dx.doi.org/10.1007/s00415-010-5566-8.
    10.1007/s00415-010-5566-8
  67. ROSA, MÁRIO MIGUEL; Ferreira, Joaquim J.; Coelho, Miguel; Freire, Rita; Sampaio, Cristina. Corresponding author: ROSA, MÁRIO MIGUEL. "Prescribing patterns of antiparkinsonian agents in Europe". Movement Disorders 25 8 (2010): 1053-1060. http://dx.doi.org/10.1002/mds.23038.
    10.1002/mds.23038
  68. ROSA, MÁRIO MIGUEL; Ferreira, Joaquim J.; Neutel, Dulce; Mestre, Tiago; Coelho, Miguel; Rosa, Mário M.; Rascol, Olivier; Sampaio, Cristina. "Skin cancer and Parkinson's disease.". Movement disorders : official journal of the Movement Disorder Society (2010): https://doi.org/10.1002/mds.22855.
    10.1002/mds.22855
  69. Mario Miguel Rosa; N. A. Aziz; C. K. Jurgens; G. B. Landwehrmeyer; W.M.C. van Roon-Mom; G. J.B. van Ommen; T. Stijnen; R. A.C. Roos; EHDN Registry Study Group. "Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease". Neurology 73 16 (2009): 1280-1285. http://dx.doi.org/10.1212/wnl.0b013e3181bd1121.
    10.1212/wnl.0b013e3181bd1121
  70. Mestre, Tiago; Ferreira, Joaquim; Coelho, Miguel M; Rosa, Mário; Sampaio, Cristina. "Therapeutic interventions for disease progression in Huntington's disease". Cochrane Database of Systematic Reviews (2009): http://dx.doi.org/10.1002/14651858.cd006455.pub2.
    10.1002/14651858.cd006455.pub2
  71. Mestre, Tiago; Ferreira, Joaquim; Coelho, Miguel M; ROSA, MÁRIO MIGUEL; Sampaio, Cristina. "Therapeutic interventions for symptomatic treatment in Huntington's disease". Cochrane Database of Systematic Reviews (2009): http://dx.doi.org/10.1002/14651858.cd006456.pub2.
    10.1002/14651858.cd006456.pub2
  72. ROSA, MÁRIO MIGUEL. "Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.". Movement disorders : official journal of the Movement Disorder Society (2009): https://doi.org/10.1002/mds.22343.
    10.1002/mds.22343
  73. Mario Miguel Rosa; P. O'Connor; G. Comi; X. Montalban; J. Antel; E. W. Radue; A. de Vera; et al. "Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study". Neurology 72 1 (2009): 73-79. http://dx.doi.org/10.1212/01.wnl.0000338569.32367.3d.
    10.1212/01.wnl.0000338569.32367.3d
  74. ROSA, MÁRIO MIGUEL. "Good clinical practice | Boas práticas clínicas". Sinapse 9 1 (2009): 51-55.
    Published
  75. Geraldes, R; Coelho, M; Rosa, M M; Severino, L; Castro, J; de Carvalho, M. "Abnormal transcranial magnetic stimulation in a patient with presumed psychogenic paralysis". Journal of Neurology, Neurosurgery & Psychiatry 79 12 (2008): 1412-1413. http://dx.doi.org/10.1136/jnnp.2008.154583.
    Published • 10.1136/jnnp.2008.154583
  76. Mario Miguel Rosa; Daniel G Healy; Mario Falchi; Sean S O'Sullivan; Vincenzo Bonifati; Alexandra Durr; Susan Bressman; et al. "Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study". The Lancet Neurology 7 7 (2008): 583-590. http://dx.doi.org/10.1016/s1474-4422(08)70117-0.
    10.1016/s1474-4422(08)70117-0
  77. Coelho, Miguel; Ferreira, Joaquim; Rosa, Mário; Sampaio, Cristina. "Treatment options for non-motor symptoms in late-stage Parkinson's disease". Expert Opinion on Pharmacotherapy 9 4 (2008): 523-535. http://dx.doi.org/10.1517/14656566.9.4.523.
    Published • 10.1517/14656566.9.4.523
  78. Ferreira, Joaquim J.; Almeida, Luis; Cunha, Luis; Ticmeanu, Marina; Rosa, Mário M.; Januário, Cristina; Mitu, Cristina-Elena; et al. "Effects of Nebicapone on Levodopa Pharmacokinetics, Catechol-O-methyltransferase Activity, and Motor Fluctuations in Patients with Parkinson Disease". Clinical Neuropharmacology 31 1 (2008): 2-18. http://dx.doi.org/10.1097/wnf.0b013e3180645cb0.
    Published • 10.1097/wnf.0b013e3180645cb0
  79. Ferreira, Joaquim; Mestre, Tiago; Hewett, Russell M; Coelho, Miguel M; ROSA, MÁRIO MIGUEL; Rascol, Olivier; Sampaio, Cristina. "Therapeutic interventions for sleep disorders in Parkinson's disease". Cochrane Database of Systematic Reviews (2007): http://dx.doi.org/10.1002/14651858.cd006809.
    10.1002/14651858.cd006809
  80. Neutel, Dulce; Ferreira, Joaquim; Coelho, Miguel M; Rosa, Mário Miguel; Rascol, Olivier; Sampaio, Cristina. "Piribedil versus levodopa in early Parkinson's disease". Cochrane Database of Systematic Reviews (2007): http://dx.doi.org/10.1002/14651858.cd006710.
    10.1002/14651858.cd006710
  81. Neutel, Dulce; Ferreira, Joaquim; Coelho, Miguel M; ROSA, MÁRIO MIGUEL; Rascol, Olivier; Sampaio, Cristina. "Piribedil for symptomatic management of Parkinson's disease". Cochrane Database of Systematic Reviews (2007): http://dx.doi.org/10.1002/14651858.cd006708.
    10.1002/14651858.cd006708
  82. Ferreira, Joaquim; Silva, João Maia; Freire, Rita; Pignatelli, João; Guedes, Leonor Correia; Feijó, Alexandra; ROSA, MÁRIO MIGUEL; et al. "Skin cancers and precancerous lesions in Parkinson's disease patients". Movement Disorders 22 10 (2007): 1471-1475. http://dx.doi.org/10.1002/mds.21575.
    10.1002/mds.21575
  83. Ferreira, Joaquim J.; Guedes, Leonor Correia; ROSA, MÁRIO MIGUEL; Coelho, Miguel; van Doeselaar, Marina; Schweiger, Dorothea; Di Fonzo, Alessio; et al. "High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal". Movement Disorders 22 8 (2007): 1194-1201. http://dx.doi.org/10.1002/mds.21525.
    10.1002/mds.21525
  84. Mario Miguel Rosa; Geser F; Gregor Wenning; Klaus Seppi; Stampfer-Kountchev M; Christoph Scherfler; Sawires M; et al. "Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).". Movement disorders : official journal of the Movement Disorder Society (2006): https://doi.org/10.1002/mds.20678.
    10.1002/mds.20678
  85. ROSA, MÁRIO MIGUEL. "[Botulinum toxin for the treatment of pain syndromes].". Acta reumatologica portuguesa (2006):
  86. Geser, F.; Seppi, K.; Stampfer-Kountchev, M.; Köllensperger, M.; Diem, A.; Ndayisaba, J. P.; Ostergaard, K.; et al. "The European Multiple System Atrophy-Study Group (EMSA-SG)". Journal of Neural Transmission 112 12 (2005): 1677-1686. http://dx.doi.org/10.1007/s00702-005-0328-y.
    10.1007/s00702-005-0328-y
  87. Emre, Murat; Aarsland, Dag; Albanese, Alberto; Byrne, E. Jane; Deuschl, Günther; De Deyn, Peter P.; Durif, Franck; et al. "Rivastigmine for Dementia Associated with Parkinson's Disease". New England Journal of Medicine 351 24 (2004): 2509-2518. http://dx.doi.org/10.1056/nejmoa041470.
    Open access • 10.1056/nejmoa041470
  88. Perani, D; Cappa, S.F; Tettamanti, M; Rosa, M; Scifo, P; Miozzo, A; Basso, A; Fazio, F. "A fMRI study of word retrieval in aphasia". Brain and Language 85 3 (2003): 357-368. http://dx.doi.org/10.1016/s0093-934x(02)00561-8.
    10.1016/s0093-934x(02)00561-8
  89. ROSA, MÁRIO MIGUEL. "[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part IV].". Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology (2001):
  90. ROSA, MÁRIO MIGUEL. "[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part III].". Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology (2001):
  91. ROSA, MÁRIO MIGUEL. "[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part II].". Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology (2001):
  92. ROSA, MÁRIO MIGUEL. "[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature. Part I].". Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology (2001):
  93. Perani, Daniela; Cappa, Stefano F.; Schnur, Tatiana; Tettamanti, Marco; Collina, Simona; Rosa, Màrio Miguel; Fazio1, Ferruccio. "The neural correlates of verb and noun processing". Brain 122 12 (1999): 2337-2344. http://dx.doi.org/10.1093/brain/122.12.2337.
    10.1093/brain/122.12.2337
Thesis / Dissertation
  1. Bonifácio, Gonçalo Vitorino. "O que os RCM (não) dizem acerca das alergias aos ß-lactâmicos". Master, 2016. http://hdl.handle.net/10451/26726.
  2. Santos, Tânia Catarina Gomes dos, 1992-. "Uma verdade conveniente sobre os ß-lactâmicos : caracterização das reacções adversas medicamentosas aos ß-lactâmicos notificadas espontaneamente nos últimos 15 anos, entre 1 janeiro de 2000 a 31 dezembro de 2015". Master, 2016. http://hdl.handle.net/10451/29539.
  3. Taborda, Filipa Alexandra Bitoque Rodrigues. "Afinal que diferença clínica tem significado no tratamento farmacológico da esclerose lateral amiotrófica? : contributo dos ensaios clínicos e análise dos endpoints de eficácia". Master, 2016. http://hdl.handle.net/10451/26549.
  4. Coelho, Pedro Miguel Inácio, 1992-. "Alterações aos RCMs e patentes : uma análise de conteúdos no grupo farmacológico das estatinas". Master, 2016. http://hdl.handle.net/10451/29358.
  5. Duarte, Ivo Miguel Santos. "Clinical practice guidelines for management of parkinson’s disease : a systematic critical appraisal". Master, 2014. http://hdl.handle.net/10451/24037.
  6. Kauppila, Linda Maria Azevedo. "Characterization of adverse drug reactions with neuropsychiatric clinical manifestations reported spontaneously to the portuguese pharmacovigilance system in the greater Lisbon area". Master, 2014. http://hdl.handle.net/10451/24347.

Other

Other output
  1. The effect of Levodopa and Stimulation on post-surgery Freezing of Gait in STN-DBS Parkinson's Disease patients: a clinical and kinematic analysis. 2024. Barbosa, R.; Bastos, P.; Lobo, P.P.; Rodrigues, C.; Valadas, A.; Guedes, L.C.; Mano, B.; et al. http://www.scopus.com/inward/record.url?eid=2-s2.0-85193306798&partnerID=MN8TOARS.
    10.21203/rs.3.rs-4058858/v1
  2. Long-term follow-up of subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease: an analysis of survival and disability milestones. 2023. Barbosa, R.; Guedes, L.C.; Cattoni, M.B.; Lobo, P.P.; Caldas, A.C.; Fabbri, M.; Bastos, P.; et al. http://www.scopus.com/inward/record.url?eid=2-s2.0-85163725620&partnerID=MN8TOARS.
    10.1101/2023.06.03.23290925
  3. Determinants of burden and quality of life of informal caregivers of individuals with dementia. 2022. Rosa, M.M.; Lindeza, P.; Ferreira, L.; Guerreiro, M.. http://www.scopus.com/inward/record.url?eid=2-s2.0-85167256115&partnerID=MN8TOARS.
    10.21203/rs.3.rs-1459396/v1
  4. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?. [Excerpt] Introduction The management of multiple sclerosis (MS) has been a neurology success story for the past 25 years. Advances in understanding of the disease mechanisms and the dynamic nature of the disease have brought around 12 disease-modifying therapies (DMTs) to market in many countries.[...]. 2018. Cerqueira, João José; Compston, D. Alastair S.; Geraldes, Ruth; Rosa, Mario M.; Schmierer, Klaus; Thompson, Alan; Tinelli, Michela; Palace, Jacqueline. http://hdl.handle.net/1822/57801.
    10.1136/jnnp-2017-317509
Activities

Committee member

Activity description
Role 		Institution / Organization
2018/10 - Current Faculdade de Farmácia UL Ethics Committe for Investigation with Humans - Ethics Committee Member
Member
 Universidade de Lisboa Faculdade de Farmácia, Portugal
2016/07/01 - Current Central Nervous System Working Party Member - Committee for Medicinal Products for Human Use
Member
 European Medicines Agency, United Kingdom
2016 - Current Campus Neurológico Sénior - Torres Vedras Ethics Committee Member
President / Vice-president
2013 - Current Comissão de Avaliação de Medicamentos
Member
 Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP, Portugal
2012/11/01 - Current Fundação Champalimaud Ethics Council Member
Member
 Fundação Champalimaud, Portugal
2011/11 - Current Scientific Advice Working Party Member - Committee for Medicinal Products for Human Use
Member
 European Medicines Agency, United Kingdom
2011/09/01 - 2020/10/23 Centro Hospitalar Lisboa Norte + Faculdade de Medicina da Universidade de Lisboa Ethics Committee Member
Member
 Universidade de Lisboa Faculdade de Medicina, Portugal
2016 - 2019 Comissão de Avaliação de Tecnologias em Saúde
Member
 Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP, Portugal
2004/07/07 - 2011 Hospital Santa Maria Ethics Committee Member
Member
 Hospital de Santa Maria, Portugal

Consulting

Activity description Institution / Organization
2012 - Current Nervous System Senior Expert - Pharmacovigilance Risk Assessment Committee European Medicines Agency, United Kingdom
2005 - Current Nervous System and Pain Senior Expert- Committee for Human Medicinal Products European Medicines Agency, United Kingdom
1998 - 2016 Clinical Pharmacology Consultant at Economic Evaluation and Market Monitoring Department Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP, Portugal
1995 - 1998 Clinical Pharmacology - Pharmacovigilance Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP, Portugal
Distinctions

Other distinction

1995 Projecto “Poder diagnóstico da tomografia de emissão de fotões com 123I-Iodobenzamida nos Síndromes
Ministério da Saúde, Portugal
1991 Bolsa de estudo de Iniciação à Investigação
1990 Prémio Sandoz de Neurologia